nVerses Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,500	Closed	-$118K	–	103
2024 Q3	$118K	Buy	15,500 +5,300	+52%	+$40.3K	0.05%	443
2024 Q2	$63K	Buy	+10,200	New	+$63K	0.04%	551